A Phase I, Open-label, Randomized, Single-center, 2-way Crossover Food Interaction Study To Assess the Effect of Food on the Pharmacokinetics of the Fixed Dose Combination Capsule of Esomeprazole 20 mg/Acetylsalicylic Acid 81 mg.

Trial Profile

A Phase I, Open-label, Randomized, Single-center, 2-way Crossover Food Interaction Study To Assess the Effect of Food on the Pharmacokinetics of the Fixed Dose Combination Capsule of Esomeprazole 20 mg/Acetylsalicylic Acid 81 mg.

Completed
Phase of Trial: Phase I

Latest Information Update: 25 Jan 2016

At a glance

  • Drugs Aspirin/esomeprazole (Primary)
  • Indications Cardiovascular disorders; Embolism and thrombosis; NSAID-induced gastrointestinal damage
  • Focus Pharmacokinetics
  • Most Recent Events

    • 06 Dec 2010 Actual initiation date changed from May 2010 to Jun 2010 as reported by ClinicalTrials.gov.
    • 06 Dec 2010 Actual end date changed from Aug 2010 to Sep 2010 as reported by ClinicalTrials.gov.
    • 29 Sep 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top